CXCL10 and neoplasm: As shown in Fig. 8c, d, STING agonist upregulated the T cell chemokine CXCL10 with little effect on the DC attractant CCL20, suggesting that STING agonist therapy increases the adaptive anti-tumor T cell responses through multiple cellular mechanisms.